Exact Mass: 436.2726

DHAP(18:0)

C21H41O7P (436.259)

DHAP(18:0) is the octadecanoyl derivative of Dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by octadecanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts. 1-Octadecyl-glycerone-3-phosphate is an intermediate in Ether lipid metabolism. DHAP(18:0) or 1-Octadecanoyl-glycerone-3-phosphate is the precursor to 1-Octadecyl-glycerone-3-phosphate DHAP(18:0e) which is generated via alkylglycerone phosphate synthase (EC: 2.5.1.26). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. Ether lipids are called plasmalogens (1-O-1-alkenyl-2-acylglycerophospholipids) if these are glycerol-containing phospholipids with an unsaturated O-(1-alkenyl) (vinyl ether) group at the first position on the glycerol chain. Plasmalogens as well as some 1-O-alkyl lipids are ubiquitous and sometimes major parts of the cell membranes in mammals and anaerobic bacteria. In archaea, ether lipids are the major polar lipids in the cell envelope and their abundance is one of the major characteristics that separate this group of prokaryotes from the bacteria. In these cells, diphytanylglycerolipids or bipolar macrocyclic tetraethers can form covalently linked bilayers. [HMDB] DHAP(18:0) is the octadecanoyl derivative of dihydroxyacetone phosphate. It is also known as an alkyl-DHAP. This compound is formed by octadecanoic acid reacting with DHAP. Alkyl-DHAPs are intermediates in the synthesis of ether phospholipids. The initial steps of ether phospholipid biosynthesis take place in peroxisomes. Alkyl-dihydroxyacetonephosphate synthase is the peroxisomal enzyme that actually introduces the ether linkage. Levels of Alkyl-DHAP have been found to be strongly reduced in human fibroblasts derived from Zellweger syndrome and rhizomelic chondrodysplasia punctata patients. Four other enzymes are known to be involved in the metabolism of acyl-DHAP and alkyl-DHAP. These include: acyl-DHAP/alkyl-DHAP oxidoreductase, DHAP acyltransferase, alkyl-DHAP phosphohydrolase, and a dinitrofluorobenzene-insensitive acyl-DHAP acylhydrolase. Dihydroxyacetone phosphate (DHAP) is a biochemical compound primarily involved in the glycolysis metabolic pathway. DHAP is also the product of the dehydrogenation of L-glycerol-3-phosphate which is part of the entry of glycerol (sourced from triglycerides) into the glycolytic pathway. Conversely, reduction of glycolysis-derived DHAP to L-glycerol-3-phosphate provides adipose cells with the activated glycerol backbone they require to synthesize new triglycerides. Both reactions are catalyzed by the enzyme glycerol 3-phosphate dehydrogenase with NAD+/NADH as cofactor. DHAP may be referred to as glycerone phosphate in older texts. 1-Octadecyl-glycerone-3-phosphate is an intermediate in Ether lipid metabolism. DHAP(18:0) or 1-Octadecanoyl-glycerone-3-phosphate is the precursor to 1-Octadecyl-glycerone-3-phosphate DHAP(18:0e) which is generated via alkylglycerone phosphate synthase (EC: 2.5.1.26). Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. Ether lipids are called plasmalogens (1-O-1-alkenyl-2-acylglycerophospholipids) if these are glycerol-containing phospholipids with an unsaturated O-(1-alkenyl) (vinyl ether) group at the first position on the glycerol chain. Plasmalogens as well as some 1-O-alkyl lipids are ubiquitous and sometimes major parts of the cell membranes in mammals and anaerobic bacteria. In archaea, ether lipids are the major polar lipids in the cell envelope and their abundance is one of the major characteristics that separate this group of prokaryotes from the bacteria. In these cells, diphytanylglycerolipids or bipolar macrocyclic tetraethers can form covalently linked bilayers. (Wikipedia)

simvastatin hydroxy acid

C25H40O6 (436.2825)

simvastatin hydroxy acid is a metabolite of simvastatin. Simvastatin is a hypolipidemic drug used to control elevated cholesterol, or hypercholesterolemia. It is a member of the statin class of pharmaceuticals. Simvastatin is a synthetic derivate of a fermentation product of Aspergillus terreus. The drug is marketed generically and under the trade name Zocor. (Wikipedia) C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor

LysoPA(18:1(9Z)/0:0)

C21H41O7P (436.259)

LysoPA(18:1(9Z)/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).

Pangamic acid

C20H40N2O8 (436.2785)

Pangamic acid is found in apricot. Pangamic acid is isolated from apricot kernel, also said to be present in cereals etc. Said to be a vitamin of significance in, inter alia, hypertension control Pangamic acid is also known as vitamin B15, but it is not widely accepted as a vitamin for it has not been shown to be essential in the human diet, and a deficiency in consumption of pangamic acid is not known to be associated with any disease. Pangamic acid is an ester derived from gluconic acid and dimethylglycine. It was first isolated by Ernst T. Krebs from apricot kernels, and has since been identified in some foods such as pulses. Also found in rice bran & apricot kernels Isolated from apricot kernel, also said to be present in cereals etc. Said to be a vitamin of significance in, inter alia, hypertension control

LysoPA(0:0/18:1(9Z))

C21H41O7P (436.259)

LysoPA(0:0/18:1(9Z)) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes. In particular, lysophosphatidic acid is an intercellular lipid mediator with growth factor-like activities, and is rapidly produced and released from activated platelets to influence target cells. 1-Palmitoyl lysophosphatidic acid is the major component of lysophosphatidic acid (LPA) in plasma, and is in a reduced ratio in individuals with gynecological cancers (PMID 11585410). LPA is a pluripotent lipid mediator controlling growth, motility, and differentiation, that has a strong influence on the chemotaxis and ultrastructure of human neutrophils (PMID 7416233). In serum and plasma, LPA is mainly converted from lysophospholipids, whereas in platelets and some cancer cells it is converted from phosphatidic acid. In each pathway, at least two phospholipase activities are required: phospholipase A1 (PLA1)/PLA2 plus lysophospholipase D (lysoPLD) activities are involved in the first pathway and phospholipase D (PLD) plus PLA1/PLA2 activities are involved in the second pathway. (PMID 15271293).

(R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol

C21H40O9 (436.2672)

(R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol is found in fruits. (R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol is a constituent of calabash tree (Crescentia cujete) fruits. Constituent of calabash tree (Crescentia cujete) fruits. (R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol is found in fruits.

(2-Hydroxy-3-phosphonooxypropyl) octadec-9-enoate

C21H41O7P (436.259)

N,N-Dihexyl-2-(4-fluorophenyl)indole-3-acetamide

C28H37FN2O (436.289)

DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C25H40O6 (436.2825)

DG(2:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C25H40O6 (436.2825)

DG(2:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C25H40O6 (436.2825)

DG(2:0/0:0/20:3(5Z,11Z,14Z)-O(8,9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C25H40O6 (436.2825)

DG(2:0/0:0/20:3(8Z,11Z,14Z)-O(5,6)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/2:0)

C25H40O6 (436.2825)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Lancifodilactone F

C25H40O6 (436.2825)

Lancifodilactone F is a tetracyclic triterpenoid that is a rearranged pentanortriterpenoid derived from cycloartane. Isolated from the leaves and stem of Schisandra lancifolia, it exhibits anti-HIV activity. It has a role as a metabolite and an anti-HIV agent. It is an oxaspiro compound, a tetracyclic triterpenoid, a gamma-lactone, a diol and a monocarboxylic acid. A tetracyclic triterpenoid that is a rearranged pentanortriterpenoid derived from cycloartane. Isolated from the leaves and stem of Schisandra lancifolia, it exhibits anti-HIV activity.

20-Hydroxytingenone

C28H36O4 (436.2613)

Melissoidesin T

C24H36O7 (436.2461)

Epoxycladine D

C24H36O7 (436.2461)

Melissoidesin J

C24H36O7 (436.2461)

Azadirone

C28H36O4 (436.2613)

A tetracyclic triterpenoid that is 4,4,8-trimethylandrosta-1,14-diene substituted by an oxo group at position 3, an acetoxy group at position 7 and a furan-3-yl group at position 17. Isolated from Azadirachta indica, it exhibits antiplasmodial and antineoplastic activities.

Melissoidesin Q

C24H36O7 (436.2461)

Leucasperone B

C24H36O7 (436.2461)

Lehualide B

C28H36O4 (436.2613)

Adenanthin H

C24H36O7 (436.2461)

Lihsienin A

C24H36O7 (436.2461)

Isobalaendiol

C28H36O4 (436.2613)

Adenanthin E

C24H36O7 (436.2461)

Inflexarabdonin A

C24H36O7 (436.2461)

Erigerol

C25H40O6 (436.2825)

Pancherin A

C25H40O6 (436.2825)

Pancherin B

C25H40O6 (436.2825)

Sargaol acetate

C29H40O3 (436.2977)

Trichurusin B

C25H40O6 (436.2825)

Amazoquinone

C28H36O4 (436.2613)

22beta-Hydroxymaytenin

C28H36O4 (436.2613)

Melissoidesin E

C24H36O7 (436.2461)

(ent-2alpha,3beta,13Z)-3-Angeloyloxy-8(17),13-labdadiene-2,15,16,18-tetrol

C25H40O6 (436.2825)

SB 322823

C24H40N2O5 (436.2937)

Grevirobstol C

C28H36O4 (436.2613)

Isoiguesterol

C29H40O3 (436.2977)

Eurystatin C

C22H36N4O5 (436.2686)

N-{1-[4-(2-methoxyphenyl)piperazin-1-yl]propan-2-yl}-N-(pyridin-2-yl)cyclohexanecarboxamide

C26H36N4O2 (436.2838)

13-hydroxy-7-oxolabda-8,14-diene 13(R)-O-alpha-L-arabinopyranoside

C25H40O6 (436.2825)

Withametelin

C28H36O4 (436.2613)

glyceryl mono-oleolyl-2-phosphate

C21H41O7P (436.259)

Picrasinol A

C24H36O7 (436.2461)

C28H36O4

C28H36O4 (436.2613)

CPB-53-1114-4

C24H36O7 (436.2461)

6alpha,7beta-diacetoxy-13,14-dihydrokolavenic acid methyl ester

C25H40O6 (436.2825)

C25H40O6

C25H40O6 (436.2825)

Me ester,20-Ac-beat-Cortolonic acid

C24H36O7 (436.2461)

Fusicoplagin C

C24H36O7 (436.2461)

1alpha,6beta,7beta,14beta-tetrahydroxy-20-isobutoxy-7alpha,20-epoxy-ent-kaur-16-en-15-one|hebeirubescensin D

C24H36O7 (436.2461)

methyl desacetylacamptoacetate

C25H40O6 (436.2825)

Gerronemin F

C29H40O3 (436.2977)

1alpha-isovaleryloxypolyachyrol

C24H36O7 (436.2461)

18-dehydroochrolifuanine A

C29H32N4 (436.2627)

9,10-epoxy-6alpha-O-tigloyl-7alphaH-8beta-O-(3-hydroxy-2-methylbutyryl)germacra-3(4)E-ene|trijugin H

C25H40O6 (436.2825)

14,15-dihydroclerodin|clerodin|dihydroclerodin|dihydroclerodin-1|dihydroclerodin-I

C24H36O7 (436.2461)

hexadecane-1,16-diol 7-caffeoyl ester

C25H40O6 (436.2825)

aplyroseol-5

C24H36O7 (436.2461)

2,3-Dihydroxy-24,29-dinor-1,3,5(10),7-friedelatetraene-6,21-dione|6-oxotingenol

C28H36O4 (436.2613)

briarellin D hydroperoxide

C24H36O7 (436.2461)

18-methylmalonyl-epi-methyltrineracetal

C25H40O6 (436.2825)

2beta,3alpha-Dihydroxy-ent-labd-7-en-15-oic acid methyl ester diacetate

C25H40O6 (436.2825)

3beta,8alpha,13,14-erythro-tetrahydroxy-labda-15,17-dien-16,19-olide

C25H40O6 (436.2825)

12,13-Di-Ac-(4xi,6beta,9alpha,12xi,13xi)-2,10(18),14-Prenylguaiatriene-4,6,9,12,13-pentol

C24H36O7 (436.2461)

1alpha,3beta,15beta-trihydroxy-7beta,11beta-diacetoxy-ent-kaur-16-ene|nervonin H

C24H36O7 (436.2461)

coagulin E

C28H36O4 (436.2613)

16-(2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-17-nor-coryn-19-ene|4,17-dihydro 17 alpha-tchibangensine

C29H32N4 (436.2627)

6alpha,11beta,15beta-trihydroxy-3beta,7beta-diacetoxy-ent-kaur-16-ene|xindongnin E

C24H36O7 (436.2461)

methyl 7beta,15-diacetoxy-8-labden-17-oate

C25H40O6 (436.2825)

(22R)-4beta-hydroxy-1-oxo-witha-2,5,16,24-tetraenolide|(4S,20S,22R)-4-hydroxy-1-oxo-witha-2,5,16,24-tetraenolide

C28H36O4 (436.2613)

12,13-Di-Ac-(3beta,6beta,9alpha,12xi,13xi)-4,10,14-Prenylguaiatriene-3,6,9,12,13-pentol

C24H36O7 (436.2461)

(2alpha,3alpha,7alpha,12?鈥?13?鈥?-3-(2-Methylbutanoyl):2,3,7-Trihydroxy-8(17)-labden-15,12-olide|2alpha,7alpha-dihydroxy-3alpha(2-methylbutanoyloxy)8(17)-labden-12,15-olide

C25H40O6 (436.2825)

19-(p-hydroxyhydrocinnamoyloxy)-ent-kaurenic acid|19--ent-kaurenic acid

C29H40O3 (436.2977)

C24H36O7

C24H36O7 (436.2461)

6alpha-hydroxy-17-isovaleroxygrindelic acid

C25H40O6 (436.2825)

sterostrein B

C28H36O4 (436.2613)

klymollin D

C24H36O7 (436.2461)

An eunicellin diterpenoid isolated from the soft coral Klyxum molle.

12beta-O-acetyl-15alpha,28-dihydoxy-17beta-methoxy-3-oxo-20,21,22,23,24,25,26,27-octanordammanran

C25H40O6 (436.2825)

6alpha,8alpha,15(S),23-tetrahydroxy-labd-13(14),17-dien-16(S),19-olide

C25H40O6 (436.2825)

palmadorin R

C25H40O6 (436.2825)

palmadorin H

C25H40O6 (436.2825)

Malonganenone N

C26H36N4O2 (436.2838)

SCHEMBL9179197

C25H40O6 (436.2825)

hirsutalin K

C24H36O7 (436.2461)

sucutinirane H

C24H36O7 (436.2461)

(5S,8R,9S,10R,13S)-2-oxo-13-O-arabinopyranosyl-3,14-clerodadiene

C25H40O6 (436.2825)

astrogorgin M

C24H36O7 (436.2461)

(+)-schizandrin

C24H36O7 (436.2461)

7alpha,14beta-dihydroxy-17alpha-ethoxymethyl-3beta-acetoxy-ent-kaur-11,15-dione

C24H36O7 (436.2461)

malonganenone L

C26H36N4O2 (436.2838)

3,3-dimethylundecan-2-yl 4-acetyl-2,3,6-trimethoxybenzoate|asiatoate A

C25H40O6 (436.2825)

15-alpha-hydroxytingenone

C28H36O4 (436.2613)

Vulgaroside

C25H40O6 (436.2825)

20(S)-1alpha,6beta,7beta-trihydroxy-20-butoxy-8,15-seco-7alpha,20-epoxy-ent-kaur-16-en-11,15-olide|parvifoline Y

C24H36O7 (436.2461)

9,10-epoxy-5beta-O-tigloyl-7alphaH-6alpha,8beta-di-O-acetylgermacra-3(4)E-ene|trijugin B

C24H36O7 (436.2461)

15,16-diacetoxy-12,13-15,16-diepoxy-14-hydroxy-neoclerod-3-ene

C24H36O7 (436.2461)

secospatacetal A

C25H40O6 (436.2825)

Oriediterpenoside

C25H40O6 (436.2825)

18-succinyloxygrindelic acid

C24H36O7 (436.2461)

3,9-dihydroxy-4,6a,6b,8a,11,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O4 (436.2613)

di-O-acetyllagohirsin

C24H36O7 (436.2461)

(20S,22S,23R,24S)-14beta,22:22,25-diepoxy-23-hydroxyergosta-4,6,8,11-tetraen-3-one|blazeispirol U

C28H36O4 (436.2613)

isoagatholal-15-O-beta-D-xylopyranoside

C25H40O6 (436.2825)

9alpha,13alpha-diacetoxy-11(15->1)abeotaxa-4(20),11-diene-5alpha,10beta,15-triol

C24H36O7 (436.2461)

6alpha,7alpha-17beta-trihydroxy-15beta,17-oxidispongian-16-one 7-butyrate|aplyroseol-3

C24H36O7 (436.2461)

isowithametelin

C28H36O4 (436.2613)

(3aS,5R,5aS,6aS,7aS,8R,8aS,8bR)-dodecahydro-3a,8b-dihydroxy-5,7a-dimethyl-1-methylideneoxireno[6,7]naphtho[2,1-b]furan-8-yl decanoate|strobilol I

C25H40O6 (436.2825)

Trunculin D

C24H36O7 (436.2461)

salvisyriacolide

C25H40O6 (436.2825)

daturilin

C28H36O4 (436.2613)

inflexarabdonin D

C24H36O7 (436.2461)

6alpha-hydroxy-17-(alpha-methylbutyroxy)grindelic acid

C25H40O6 (436.2825)

5alpha,13alpha-dihydroxy-9alpha,10beta-diacetoxy-11(15->1)-abeo-taxa-4(20),11-diene

C24H36O7 (436.2461)

4,17beta-dihydrotchibangensine

C29H32N4 (436.2627)

methyl 3alpha,15-diacetoxy-labd-8(17)-en-19-oate

C25H40O6 (436.2825)

C29H40O3

C29H40O3 (436.2977)

16-(2,3,4,9-tetrahydro-1H-beta-carbolin-1-yl)-16-nor-coryn-3(14)-ene|3-Dehydrochrolifuanin|3-Dehydroochrolifuanin

C29H32N4 (436.2627)

Leu Lys Tyr

C22H36N4O5 (436.2686)

Leu Tyr Lys

C22H36N4O5 (436.2686)

Lys Leu Tyr

C22H36N4O5 (436.2686)

Tyr Leu Lys

C22H36N4O5 (436.2686)

Lys Tyr Leu

C22H36N4O5 (436.2686)

Tyr Lys Leu

C22H36N4O5 (436.2686)

Withasomniferolide A

C28H36O4 (436.2613)

Withasomniferolide B

C28H36O4 (436.2613)

legonoxamine D

C22H36N4O5 (436.2686)

Simvastatin acid

C25H40O6 (436.2825)

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor

Diacetyl-10-gingerdiol

C25H40O6 (436.2825)

PA(18:1/0:0)

C21H41O7P (436.259)

Oleoyl lysophosphatidic acid

C21H41O7P (436.259)

(5Z,7E)-(1S,3R)-24-methylsulfonyl-9,10-seco-5,7,10(19)-cholatriene-1,3-diol

C25H40O4S (436.2647)

LysoPA(18:1)

C21H41O7P (436.259)

(-)-Salvisyriacolide

C25H40O6 (436.2825)

1-Oleoyl Lysophosphatidic Acid (sodium salt)

C21H41O7P (436.259)

Vitamin B15

C20H40N2O8 (436.2785)

(R)-1-O-[b-D-Apiofuranosyl-(1->2)-b-D-glucopyranoside]-1,3-octanediol

C21H40O9 (436.2672)

LPA 18:1

C21H41O7P (436.259)

ST 28:6;O3

C28H36O4 (436.2613)

1alpha-hydroxy-24-methylsulfonyl-25,26,27-trinorvitamin D3

C25H40O4S (436.2647)

N-[2-[4-(2-METHOXYPHENYL)PIPERAZINO]-1-METHYLETHYL]-N-PYRIDIN-2-YLCYCLOHEXANECARBOXAMIDE

C26H36N4O2 (436.2838)

Forskolin G

C24H36O7 (436.2461)

Bolmantalate

C29H40O3 (436.2977)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

tetra-n-butyllead

C16H36Pb (436.2583)

Lifarizine

C29H32N4 (436.2627)

C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C93038 - Cation Channel Blocker

BOC-L-2-FURYLALANINE DCHA SALT

C24H40N2O5 (436.2937)

4-Pentyloxyphenyl-4-Trans-PentylcyclohexylBenzo

C29H40O3 (436.2977)

BIS(4-(VINYLOXYMETHYL)CYCLOHEXYLMETHYL)&

C25H40O6 (436.2825)

FGIN-1-27

C28H37FN2O (436.289)

D006133 - Growth Substances > D010937 - Plant Growth Regulators > D007210 - Indoleacetic Acids

(trans,trans)-4-Pentyl-[1,1-bicyclohexyl]-4-carboxylic acid 4-ethoxy-2,3-difluorophenyl ester

C26H38F2O3 (436.2789)

dodecyl 2-methylprop-2-enoate,3,3,3-trifluoropropyl 2-methylprop-2-enoate

C23H39F3O4 (436.28)

Cipemastat

C22H36N4O5 (436.2686)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C1970 - Matrix Metalloproteinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

1-Oleoyl Lysophosphatidic Acid

C21H41O7P (436.259)

Dimethyl-amino-acetylgluconic acid

C20H40N2O8 (436.2785)

N~2~-1,3-Benzoxazol-2-YL-3-cyclohexyl-N-{2-[(4-methoxyphenyl)amino]ethyl}-L-alaninamide

C25H32N4O3 (436.2474)

pangamic acid

C20H40N2O8 (436.2785)

1-Stearoyl-sn-glycero-3-phosphate(2-)

C21H41O7P-2 (436.259)

(2S)-2-azaniumyl-5-[[(2R)-1-[[2-[4-(3-azaniumylpropylazaniumyl)butylamino]-2-oxoethyl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-5-oxopentanoate

C17H36N6O5S+2 (436.2468)

2-Stearoyl-sn-glycerol 3-phosphate

C21H41O7P-2 (436.259)

[(2R)-2-hydroxy-3-phosphonooxypropyl] (E)-octadec-11-enoate

C21H41O7P (436.259)

[(2R)-2-hydroxy-3-phosphonooxypropyl] (Z)-octadec-11-enoate

C21H41O7P (436.259)

3-[2-[(3S,5R,8R,9S,10S,13R,14S,17S)-3,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-3-oxopropanoic acid

C24H36O7 (436.2461)

DG(2:0/20:3(5Z,8Z,11Z)-O(14R,15S)/0:0)

C25H40O6 (436.2825)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:3(5Z,8Z,11Z)-O(14R,15S))

C25H40O6 (436.2825)

DG(20:3(5Z,8Z,11Z)-O(14R,15S)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:3(5Z,8Z,14Z)-O(11S,12R)/0:0)

C25H40O6 (436.2825)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:3(5Z,8Z,14Z)-O(11S,12R))

C25H40O6 (436.2825)

DG(20:3(5Z,8Z,14Z)-O(11S,12R)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:3(5Z,11Z,14Z)-O(8,9)/0:0)

C25H40O6 (436.2825)

DG(20:3(5Z,11Z,14Z)-O(8,9)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:3(5Z,11Z,14Z)-O(8,9))

C25H40O6 (436.2825)

DG(20:3(5Z,11Z,14Z)-O(8,9)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:3(8Z,11Z,14Z)-O(5,6)/0:0)

C25H40O6 (436.2825)

DG(20:3(8Z,11Z,14Z)-O(5,6)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:3(8Z,11Z,14Z)-O(5,6))

C25H40O6 (436.2825)

DG(20:3(8Z,11Z,14Z)-O(5,6)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(20))

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(20)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0)

C25H40O6 (436.2825)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(6E,8Z,11Z,14Z)-OH(5S))

C25H40O6 (436.2825)

DG(20:4(6E,8Z,11Z,14Z)-OH(5S)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(19S))

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(19S)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(18R))

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(18R)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(17))

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(17)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,11Z,14Z)-OH(16R))

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,14Z)-OH(16R)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,11Z,13E)-OH(15S))

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,11Z,13E)-OH(15S)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,8Z,10E,14Z)-OH(12S))

C25H40O6 (436.2825)

DG(20:4(5Z,8Z,10E,14Z)-OH(12S)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0)

C25H40O6 (436.2825)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5E,8Z,12Z,14Z)-OH(11R))

C25H40O6 (436.2825)

DG(20:4(5E,8Z,12Z,14Z)-OH(11R)/0:0/2:0)

C25H40O6 (436.2825)

DG(2:0/20:4(5Z,7E,11Z,14Z)-OH(9)/0:0)

C25H40O6 (436.2825)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/2:0/0:0)

C25H40O6 (436.2825)

DG(2:0/0:0/20:4(5Z,7E,11Z,14Z)-OH(9))

C25H40O6 (436.2825)

DG(20:4(5Z,7E,11Z,14Z)-OH(9)/0:0/2:0)

C25H40O6 (436.2825)

14,15-Dihydroclerodin

C24H36O7 (436.2461)

A diterpenoid isolated from the aerial parts of Ajuga bracteosa and has been shown to exhibit antifeedant activity.

Glutathionylspermidinium(2+)

C17H36N6O5S+2 (436.2468)

1-Palmityl-2-acetyl-sn-glycero-3-phosphate(2-)

C21H41O7P-2 (436.259)

N-[2-(cyclopentylamino)-2-oxoethyl]-N-(3,4-dimethylphenyl)-N-(2-pyridinyl)pentanediamide

C25H32N4O3 (436.2474)

6,8-dimethyl-3-[(3-methyl-1-piperidinyl)-[1-(2-oxolanylmethyl)-5-tetrazolyl]methyl]-1H-quinolin-2-one

C24H32N6O2 (436.2587)

N-[2-(cyclopentylamino)-2-oxoethyl]-N-(4-methoxyphenyl)-6-(1-piperidinyl)-3-pyridinecarboxamide

C25H32N4O3 (436.2474)

2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.2549)

2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.2549)

2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.2549)

(10S,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2726)

(10S,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2726)

2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.2549)

2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.2549)

(10S,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2726)

(10R,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2726)

2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.2549)

2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(3,3,3-trifluoropropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(cyclohexylmethyl)acetamide

C21H35F3N2O4 (436.2549)

(2S,3S,3aR,9bR)-N-(cyclohexylmethyl)-3-(hydroxymethyl)-1-methyl-6-oxo-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C25H32N4O3 (436.2474)

(2R,3R,3aS,9bS)-N-(cyclohexylmethyl)-3-(hydroxymethyl)-1-methyl-6-oxo-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C25H32N4O3 (436.2474)

4-[(3aR,4R,9bR)-1-[2-(dimethylamino)-1-oxoethyl]-4-(hydroxymethyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-8-yl]-N,N-dimethylbenzamide

C25H32N4O3 (436.2474)

(10R,11S)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2726)

(10R,11R)-10-[[cyclopropylmethyl(methyl)amino]methyl]-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-14-one

C27H36N2O3 (436.2726)

2-[(E)-5-[(1R,2R,4S,5S,6R,8aS)-2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]-3-methylpent-2-enyl]-3-methyl-2H-uran-5-one

C25H40O6 (436.2825)

Mgdg O-8:0_4:0

C21H40O9 (436.2672)

Mgdg O-9:0_3:0

C21H40O9 (436.2672)

Mgdg O-10:0_2:0

C21H40O9 (436.2672)

[(E)-2-(hexanoylamino)-3-hydroxynon-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.2702)

[(E)-2-acetamido-3-hydroxytridec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.2702)

[(E)-3-hydroxy-2-(pentanoylamino)dec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.2702)

[(E)-3-hydroxy-2-(propanoylamino)dodec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.2702)

[(E)-2-(butanoylamino)-3-hydroxyundec-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.2702)

[(E)-2-(heptanoylamino)-3-hydroxyoct-4-enyl] 2-(trimethylazaniumyl)ethyl phosphate

C20H41N2O6P (436.2702)

Stearoylglycerone phosphate

C21H41O7P (436.259)

1-Oleoyl-sn-glycerol 3-phosphate

C21H41O7P (436.259)

A 1-acyl-sn-glycerol 3-phosphate having oleoyl as the 1-O-acyl group.

1-Stearoyl-sn-glycero-3-phosphate(2-)

C21H41O7P (436.259)

A 1-acyl-sn-glycerol 3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-stearoyl-sn-glycero-3-phosphate.

2-Oleoyl-LPA

C21H41O7P (436.259)

2-hydroxy-3-(phosphonooxy)propyl octadec-9-enoate

C21H41O7P (436.259)

6-[2,2-Bis[di(propan-2-yl)amino]acetyl]oxy-2,3,4,5-tetrahydroxyhexanoic acid

C20H40N2O8 (436.2785)

Paraminabeolide A

C28H36O4 (436.2613)

A withanolide that is 22,26-epoxyergosta-1,4,24-triene-18-al substituted by oxo groups at positions 3 and 26. Isolated from a Formosan soft coral, Paraminabea acronocephala, it exhibits cytotoxic activity.

2-oleoyl-sn-glycero-3-phosphate

C21H41O7P (436.259)

A 2-acyl-sn-glycerol 3-phosphate in which the phosphatidyl acyl group is specified as oleoyl.

1-Palmityl-2-acetyl-sn-glycero-3-phosphate(2-)

C21H41O7P (436.259)

A 1-alkyl-2-acyl-sn-glycero-3-phosphate(2-) obtained by deprotonation of the phosphate OH groups of 1-palmityl-2-acetyl-sn-glycero-3-phosphate; major species at pH 7.3.

1-Stearoylglycerone 3-phosphate

C21H41O7P (436.259)

1-octadec-9-enoylglycero-3-phosphate

C21H41O7P (436.259)

Glutathionylspermidinium(2+)

C17H36N6O5S (436.2468)

Dication of glutathionylspermidine arising from deprotonation of the terminal carboxy group and protonation of the primary and secondary amino groups; major species at pH 7.3.

TG(22:3)

C25H40O6 (436.2825)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

LPEt(16:1)

C21H41O7P (436.259)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

FAHFA 10:3/O-18:6

C28H36O4 (436.2613)

FAHFA 12:4/O-16:5

C28H36O4 (436.2613)

FAHFA 13:4/O-15:5

C28H36O4 (436.2613)

FAHFA 15:5/O-13:4

C28H36O4 (436.2613)

FAHFA 16:5/O-12:4

C28H36O4 (436.2613)

FAHFA 18:6/O-10:3

C28H36O4 (436.2613)

FAHFA 19:6/O-9:3

C28H36O4 (436.2613)

FAHFA 9:3/O-19:6

C28H36O4 (436.2613)

MGMG 12:0

C21H40O9 (436.2672)

LPA 0:0/18:1(9Z)

C21H41O7P (436.259)

LPA 18:1/0:0

C21H41O7P (436.259)

PA O-14:0/4:1

C21H41O7P (436.259)

PA O-14:1/4:0

C21H41O7P (436.259)

PA O-16:1/2:0

C21H41O7P (436.259)

PA O-18:1

C21H41O7P (436.259)

PA P-14:0/4:0

C21H41O7P (436.259)

PA P-14:0/4:0 or PA O-14:1/4:0

C21H41O7P (436.259)

PA P-16:0/2:0

C21H41O7P (436.259)

PA P-16:0/2:0 or PA O-16:1/2:0

C21H41O7P (436.259)

PA P-18:0

C21H41O7P (436.259)

PA P-18:0 or PA O-18:1

C21H41O7P (436.259)

LPEth 16:1

C21H41O7P (436.259)

LPM 17:1

C21H41O7P (436.259)

ST 18:1;O;GlcA

C24H36O7 (436.2461)

ST 18:2;O2;Hex

C24H36O7 (436.2461)

ST 19:1;O;Hex

C25H40O6 (436.2825)

ST 25:2;O;S

C25H40O4S (436.2647)

ST 24:3;O7

C24H36O7 (436.2461)

ST 25:2;O6

C25H40O6 (436.2825)

ST 28:7;O4

C28H36O4 (436.2613)

ST 29:6;O3

C29H40O3 (436.2977)

(1s,3br,4r,5ar,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O4 (436.2613)

(2r,3s,4r,5r)-6-{[2,2-bis(diisopropylamino)acetyl]oxy}-2,3,4,5-tetrahydroxyhexanoic acid

C20H40N2O8 (436.2785)

[8-(acetyloxy)-5-(1,3-dihydroxy-3-methylpent-4-en-1-yl)-1,5,6-trimethyl-2-oxo-4,6,7,8-tetrahydro-3h-naphthalen-1-yl]methyl acetate

C24H36O7 (436.2461)

3,18-dihydroxy-5,5,9-trimethyl-14-oxo-15,17-dioxapentacyclo[11.5.1.0¹,¹⁰.0⁴,⁹.0¹⁶,¹⁹]nonadecan-2-yl butanoate

C24H36O7 (436.2461)

(2r,3r,4s,6r,7s)-2-{[(1s,2r,4ar,8ar)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]methyl}-4-(acetyloxy)-7-hydroxy-1,5-dioxaspiro[2.4]heptan-6-yl acetate

C24H36O7 (436.2461)

2-[(1as,2r,2as,3r,5's,6ar,7s,7as)-3,7-dihydroxy-1a,2a,5',6,6-pentamethyl-hexahydrospiro[naphtho[2,3-b]oxirene-2,2'-oxolan]-5'-yl]ethyl 3-methylbut-2-enoate

C25H40O6 (436.2825)

2,3-dimethoxy-5-methyl-6-[(2e,6z,9e)-3,7,9-trimethyl-11-phenylundeca-2,6,9-trien-1-yl]pyran-4-one

C28H36O4 (436.2613)

ethyl (3r,5r)-7-[(1s,2s,8s,8ar)-2-methyl-8-{[(2s)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate

C25H40O6 (436.2825)

(1'r,2s,3r,4s,10's,14'r,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

C28H36O4 (436.2613)

1-[1-(4,5-dihydroxy-3-methylidenepentyl)-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)

{5-[(acetyloxy)methyl]-1-[2-(5-methoxyoxolan-3-yl)ethyl]-1,2-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl}methyl acetate

C25H40O6 (436.2825)

(1s,2s,4r,6s,8s,9r,10s,11s,13s,15r)-6-(acetyloxy)-8,11,15-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate

C24H36O7 (436.2461)

6-(acetyloxy)-3,8,11-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate

C24H36O7 (436.2461)

(1r,5r,8r)-8-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613)

(2r)-2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]chromen-6-yl acetate

C29H40O3 (436.2977)

(1s,3s,4r,6s,8s,9s,10r,11s,13s,15r)-6-(acetyloxy)-8,11,15-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate

C24H36O7 (436.2461)

(1r,5s,7r)-7-[(1s,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613)

(1r,3bs,4r,5ar,9as,9bs,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O4 (436.2613)

(1r,3s,4r,6s,8s,9r,10r,11s,13s,15r)-6-(acetyloxy)-3,8,11-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-15-yl acetate

C24H36O7 (436.2461)

1,16-dihydroxyhexadecan-7-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate

C25H40O6 (436.2825)

(1s,2s,3s,4s,5s,6e,10r)-2,4-bis(acetyloxy)-3-isopropyl-6,10-dimethyl-11-oxabicyclo[8.1.0]undec-6-en-5-yl (2e)-2-methylbut-2-enoate

C24H36O7 (436.2461)

(1r,2s,5s,6r,10r,11s,12r,15r,19s)-11-ethoxy-6-(furan-3-yl)-1,5,10,15-tetramethyl-13-oxapentacyclo[10.6.1.0²,¹⁰.0⁵,⁹.0¹⁵,¹⁹]nonadeca-8,16-dien-18-one

C28H36O4 (436.2613)

(2r,3r,4s,5r)-3,5-dihydroxy-2-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-4-yl 2-methylbut-2-enoate

C25H40O6 (436.2825)

(6bs,7s,8as,11r,12ar,12bs,14as)-3,7-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O4 (436.2613)

ethyl 3,5-dihydroxy-7-{2-methyl-8-[(2-methylbutanoyl)oxy]-1,2,6,7,8,8a-hexahydronaphthalen-1-yl}heptanoate

C25H40O6 (436.2825)

1-[(1r,2r,4ar,8ar)-1-[(4s)-4,5-dihydroxy-3-methylidenepentyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)

5-[4-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-6-[(3-methylbutanoyl)oxy]-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C25H40O6 (436.2825)

(8ar,9s,10r,11s,12as,12bs,14as)-3,9,10-trihydroxy-4,7,8a,11,12b,14a-hexamethyl-8,9,10,11,12,12a,13,14-octahydropicen-2-one

C28H36O4 (436.2613)

methyl (3r)-5-[(1r,2s,3r,4r,4ar,8ar)-3,4-bis(acetyloxy)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpentanoate

C25H40O6 (436.2825)

(1s,2r,3r,4s,6s,9s,10s,11s,13s,15r)-6-(acetyloxy)-2,11,15-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate

C24H36O7 (436.2461)

9,10,15,18-tetrahydroxy-12,12-dimethyl-6-methylidene-16-(2-methylpropoxy)-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one

C24H36O7 (436.2461)

2α,5α,9α-trihydroxy-10β,13α-diacetoxytaxa-4(20),11-diene

C24H36O7 (436.2461)

{"Ingredient_id": "HBIN005248","Ingredient_name": "2\u03b1,5\u03b1,9\u03b1-trihydroxy-10\u03b2,13\u03b1-diacetoxytaxa-4(20),11-diene","Alias": "NA","Ingredient_formula": "C24H36O7","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "21689","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

6-oxotingenol

C28H36O4 (436.2613)

{"Ingredient_id": "HBIN012741","Ingredient_name": "6-oxotingenol","Alias": "NA","Ingredient_formula": "C28H36O4","Ingredient_Smile": "CC1CC2C(CCC3(C2(CCC4(C3=CC(=O)C5=C(C(=C(C=C54)O)O)C)C)C)C)(CC1=O)C","Ingredient_weight": "436.6 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16418","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10410773","DrugBank_id": "NA"}

adenanthin e

C24H36O7 (436.2461)

{"Ingredient_id": "HBIN014676","Ingredient_name": "adenanthin e","Alias": "NA","Ingredient_formula": "C24H36O7","Ingredient_Smile": "CC(=O)OC1CC2C(C(CC(C2(C3C14CC(CC3O)C(=C)C4O)C)O)OC(=O)C)(C)C","Ingredient_weight": "436.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "609","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10982976","DrugBank_id": "NA"}

adenanthin h

C24H36O7 (436.2461)

{"Ingredient_id": "HBIN014679","Ingredient_name": "adenanthin h","Alias": "NA","Ingredient_formula": "C24H36O7","Ingredient_Smile": "CC(=O)OC1CC2C(C(CC(C2(C3C14CC(CC3O)C(=C)C4O)C)OC(=O)C)O)(C)C","Ingredient_weight": "436.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "612","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10972161","DrugBank_id": "NA"}

1-{5-[7-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl} 4-methyl butanedioate

C25H40O6 (436.2825)

(1'r,2s,3r,4s,10's,14's,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

C28H36O4 (436.2613)

(1s,2s,6s,7s,9r,11s,13s,14r,15s,16s,17s)-11-hydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-3-oxo-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-16-yl acetate

C24H36O7 (436.2461)

[(3ar,3br,4r,5as,9as,9br,11as)-4-(acetyloxy)-11a-hydroxy-6,6,9a-trimethyl-1-oxo-decahydro-3h-phenanthro[1,2-c]furan-3b-yl]methyl acetate

C24H36O7 (436.2461)

methyl 5-[3,4-bis(acetyloxy)-1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]-3-methylpentanoate

C25H40O6 (436.2825)

(1s,2s,3r,4r,5r,7s,8r,11s,12r,14r,17s)-12-(acetyloxy)-14-hydroxy-5,8,11-trimethyl-15-methylidene-10,18-dioxatetracyclo[9.7.0.0²,⁷.0³,¹⁷]octadecan-4-yl acetate

C24H36O7 (436.2461)

(2e)-n-[(3s,7r,10r)-2,9-dihydroxy-3-isopropyl-7-methyl-5,6-dioxo-1,4,8-triazacyclotrideca-1,8-dien-10-yl]-6-methylhept-2-enimidic acid

C22H36N4O5 (436.2686)

(1r,5s,8r)-8-[(1r,3as,3bs,9ar,9bs,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613)

(1s,2s,6s,7s,9r,13s,14r,15s,16s,17s)-11-hydroxy-4,15-dimethoxy-2,6,14,17-tetramethyl-3-oxo-10-oxatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadec-4-en-16-yl acetate

C24H36O7 (436.2461)

6-(acetyloxy)-8,11,15-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-2-yl acetate

C24H36O7 (436.2461)

(2s,3e,12bs)-3-ethylidene-2-[(1s)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H32N4 (436.2627)

2-[(1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-6-(acetyloxy)-7-hydroxy-1,5-dioxaspiro[2.4]heptan-4-yl acetate

C24H36O7 (436.2461)

4-hydroxy-5,5,5',8a-tetramethyl-2-{[(2-methylbutanoyl)oxy]methyl}-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid

C25H40O6 (436.2825)

(1r,2s,5s,8r,9r,10s,11r,15s,16s,18r)-16-butoxy-9,10,15,18-tetrahydroxy-12,12-dimethyl-6-methylidene-17-oxapentacyclo[7.6.2.1⁵,⁸.0¹,¹¹.0²,⁸]octadecan-7-one

C24H36O7 (436.2461)

methyl (1r,2r,4ar,5s,8ar)-2-(acetyloxy)-5-[(3s)-5-(acetyloxy)-3-methylpentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

C25H40O6 (436.2825)

6-(acetyloxy)-8,11,15-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-3-yl acetate

C24H36O7 (436.2461)

6-(acetyloxy)-3,8,15-trihydroxy-5,5,9-trimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-11-yl acetate

C24H36O7 (436.2461)

3-ethylidene-2-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H32N4 (436.2627)

(6bs,8as,11r,12ar,12bs,14ar)-3-hydroxy-11-(hydroxymethyl)-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,10,12,12a,13,14-octahydropicen-2-one

C29H40O3 (436.2977)

3-ethenyl-2-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H32N4 (436.2627)

7-{9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613)

1-[(1s,2r,4as,8ar)-1-[(3r)-4-methoxy-3-methyl-4-oxobutyl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)

(6bs,8ar,9s,11r,12as,12bs,14ar)-3,9-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O4 (436.2613)

(2r)-2-[(3s,3as,5as,7s,8r,10ar,10br)-8-[(2s)-1,2-dihydroxypropan-2-yl]-3a,10b-dimethyl-5'-oxo-decahydro-1h-spiro[cyclohepta[e]indene-7,2'-oxolan]-3-yl]propanoic acid

C25H40O6 (436.2825)

(2r,3r,4s,5r)-3,5-dihydroxy-2-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl (2z)-2-methylbut-2-enoate

C25H40O6 (436.2825)

(1'r,2s,3r,4s,14's,15'r,16's)-3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

C28H36O4 (436.2613)

1-[1-(4-methoxy-3-methyl-4-oxobutyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)

11-hydroxy-10-methoxy-2,4a,6a,9,12b,14a-hexamethyl-2,4,5,6,6b,13,14,14b-octahydro-1h-picen-3-one

C29H40O3 (436.2977)

(6ar,6br,8as,11r,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydro-6ah-picene-2,6,10-trione

C28H36O4 (436.2613)

(5s)-5-[(2e)-5-[(1r,2r,4s,4ar,5r,6s,8as)-2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-en-1-yl]-4-methyl-5h-furan-2-one

C25H40O6 (436.2825)

methyl (1r,4s,5r,9s,10s,13r,15s)-15-(benzoyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C28H36O4 (436.2613)

methyl 2-(acetyloxy)-5-[5-(acetyloxy)-3-methylpentyl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalene-1-carboxylate

C25H40O6 (436.2825)

2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]chromen-6-yl acetate

C29H40O3 (436.2977)

2-[8-(1,2-dihydroxypropan-2-yl)-3a,10b-dimethyl-5'-oxo-decahydro-1h-spiro[cyclohepta[e]indene-7,2'-oxolan]-3-yl]propanoic acid

C25H40O6 (436.2825)

(2s,3r,12bs)-3-ethenyl-2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,3h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H32N4 (436.2627)

(6as,6br,8as,11r,12ar,12bs,14ar)-3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydro-6ah-picene-2,6,10-trione

C28H36O4 (436.2613)

(3ar,7r,7as)-6-[(3ar,9r,9as)-9-hydroxy-2,2,9-trimethyl-4-oxo-1h,3h,3ah,9ah-cyclopenta[b]naphthalen-6-yl]-7-hydroxy-2,2,7-trimethyl-1,3,3a,7a-tetrahydroinden-4-one

C28H36O4 (436.2613)

[(1s,4s,5r,9s,10r,13r)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl 3-(4-hydroxyphenyl)propanoate

C29H40O3 (436.2977)

methyl (3r,5r)-7-[(1s,2s,6r,8s,8ar)-2,6-dimethyl-8-{[(2s)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate

C25H40O6 (436.2825)

1-{5-[2-(5-methoxyoxolan-3-yl)ethyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl}methyl 3-methyl propanedioate

C25H40O6 (436.2825)

(2s,3s,4r,5r)-2-{[(3e)-4-[(2r,3r)-3-[(3r,4r)-4-ethenyl-4-methyl-3-(prop-1-en-2-yl)cyclohexyl]-3-methyloxiran-2-yl]-2-methylbut-3-en-2-yl]oxy}oxane-3,4,5-triol

C25H40O6 (436.2825)

(7r)-1,16-dihydroxyhexadecan-7-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate

C25H40O6 (436.2825)

(2s,3r)-2-[(2s,4r,6e)-4,6-dimethyloct-6-en-2-yl]-6-oxooxan-3-yl (2e,4e,6r)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H40O6 (436.2825)

methyl 15-(benzoyloxy)-5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecane-5-carboxylate

C28H36O4 (436.2613)

2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),13,16,24,27-octaene-5,26,27-triol

C28H36O4 (436.2613)

3,7-dihydroxy-1,1,4a-trimethyl-5-[(3-methyl-5-oxooxolan-2-yl)methyl]-6-methylidene-hexahydro-2h-naphthalen-2-yl 2-methylbutanoate

C25H40O6 (436.2825)

3,9-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O4 (436.2613)

(1r,2r,10r,11s,14r,15r,16s)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,6-dien-9-one

C28H36O4 (436.2613)

(6bs,8as,11s,12ar,12bs,14ar)-3,11-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C28H36O4 (436.2613)

1-[(4ar,5s,6r,8ar)-5-{2-[(3s,5s)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O6 (436.2825)

(14z,17z)-2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),14,17,24,27-octaene-5,26,27-triol

C28H36O4 (436.2613)

(6bs,8as,11r,12ar,14ar)-3,11-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C28H36O4 (436.2613)

(4as,8as)-3,4a,8,8-tetramethyl-4-[(3r)-3-methyl-3-{[(2s,3r,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}pent-4-en-1-yl]-5,6,7,8a-tetrahydro-1h-naphthalen-2-one

C25H40O6 (436.2825)

10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

C28H36O4 (436.2613)

(2s,3r,4as,5r,7r,8ar)-3,7-dihydroxy-1,1,4a-trimethyl-5-{[(2s,3r)-3-methyl-5-oxooxolan-2-yl]methyl}-6-methylidene-hexahydro-2h-naphthalen-2-yl (2r)-2-methylbutanoate

C25H40O6 (436.2825)

2,6-dihydroxy-8,13-dimethyl-3-methylidene-5,12-dioxatetracyclo[7.5.0.0²,⁶.0¹¹,¹³]tetradecan-14-yl decanoate

C25H40O6 (436.2825)

2,8-dimethyl-2-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)chromen-6-yl acetate

C29H40O3 (436.2977)

3,7-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydropicene-2,10-dione

C28H36O4 (436.2613)

3,4a,8,8-tetramethyl-4-{3-methyl-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]pent-4-en-1-yl}-5,6,7,8a-tetrahydro-1h-naphthalen-2-one

C25H40O6 (436.2825)

(1s,4s,4as,5'r,8as)-4-hydroxy-5,5,5',8a-tetramethyl-2-({[(2r)-2-methylbutanoyl]oxy}methyl)-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid

C25H40O6 (436.2825)

(1s,2r,6s,8r,9s,11s,13s,14r)-2,6-dihydroxy-8,13-dimethyl-3-methylidene-5,12-dioxatetracyclo[7.5.0.0²,⁶.0¹¹,¹³]tetradecan-14-yl decanoate

C25H40O6 (436.2825)

1-[(4ar,5s,6r,8ar)-5-{2-[(3s,5r)-5-methoxyoxolan-3-yl]ethyl}-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C25H40O6 (436.2825)

(3r)-n-{2-[(1e,7ar)-3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene]acetyl}-3-hydroxyhexadecanimidic acid

C24H40N2O5 (436.2937)

3-hydroxy-5-[5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1-(hydroxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl 2-methylbut-2-enoate

C25H40O6 (436.2825)

{5,9-dimethyl-14-methylidenetetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl}methyl 3-(4-hydroxyphenyl)propanoate

C29H40O3 (436.2977)

(1s,4ar,5s,8ar)-1,4a-dimethyl-5-[(3e)-3-methyl-5-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}pent-3-en-1-yl]-6-methylidene-hexahydro-2h-naphthalene-1-carbaldehyde

C25H40O6 (436.2825)

[(1s,2s,3r,5r,10r,11r,14s,16r,17r)-3,17-dihydroxy-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosan-17-yl]methyl acetate

C25H40O6 (436.2825)

{3,17-dihydroxy-2,7,7,10-tetramethyl-6,8-dioxapentacyclo[14.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosan-17-yl}methyl acetate

C25H40O6 (436.2825)

(2r,4as,6ar,6bs,12br,14as,14br)-11-hydroxy-10-methoxy-2,4a,6a,9,12b,14a-hexamethyl-2,4,5,6,6b,13,14,14b-octahydro-1h-picen-3-one

C29H40O3 (436.2977)

4-methyl-5-[(2z)-3-methyl-5-[2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]pent-2-en-1-yl]-5h-furan-2-one

C25H40O6 (436.2825)

(5e)-5-[(2s,3s)-5-[(1r,2r,4ar,6s,8as)-2,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]-2,3-dihydroxy-3-methylpentylidene]-4-methylfuran-2-one

C25H40O6 (436.2825)

(13z,16z)-2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),13,16,24,27-octaene-5,26,27-triol

C28H36O4 (436.2613)

(2r,3z,12bs)-3-ethylidene-2-{3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,4h,6h,7h,7ah,12h,12ah,12bh-indolo[2,3-a]quinolizine

C29H32N4 (436.2627)

(2s,3r,4r,5s)-3,5-dihydroxy-2-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl (2z)-2-methylbut-2-enoate

C25H40O6 (436.2825)

1-(2e)-5-[(1s,4ar,5s,7r,8ar)-7-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-en-1-yl 4-methyl butanedioate

C25H40O6 (436.2825)

(2s)-2-hydroxy-3-[(9z)-octadec-9-enoyloxy]propoxyphosphonic acid

C21H41O7P (436.259)

4-hydroxy-5,5,5',8a-tetramethyl-2-{[(3-methylbutanoyl)oxy]methyl}-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid

C25H40O6 (436.2825)

1-[1-(4,5-dihydroxy-3-methylidenepentyl)-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)

(2s)-2,8-dimethyl-2-[(3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl]chromen-6-yl acetate

C29H40O3 (436.2977)

4-methyl-5-{3-methyl-5-[2,4,6-trihydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-hexahydro-1h-naphthalen-1-yl]pent-2-en-1-yl}-5h-furan-2-one

C25H40O6 (436.2825)

(2e)-n-(2,9-dihydroxy-3-isopropyl-7-methyl-5,6-dioxo-1,4,8-triazacyclotrideca-1,8-dien-10-yl)-6-methylhept-2-enimidic acid

C22H36N4O5 (436.2686)

(1s,2s,3s,4as,5r,8as)-3-hydroxy-5-[(3z)-5-hydroxy-3-(hydroxymethyl)pent-3-en-1-yl]-1-(hydroxymethyl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-2-yl (2z)-2-methylbut-2-enoate

C25H40O6 (436.2825)

n-(2,9-dihydroxy-3-isopropyl-7-methyl-5,6-dioxo-1,4,8-triazacyclotrideca-1,8-dien-10-yl)-6-methylhept-2-enimidic acid

C22H36N4O5 (436.2686)

(13z,16e)-2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),13,16,24,27-octaene-5,26,27-triol

C28H36O4 (436.2613)

3,9,10-trihydroxy-4,7,8a,11,12b,14a-hexamethyl-8,9,10,11,12,12a,13,14-octahydropicen-2-one

C28H36O4 (436.2613)

8-{9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613)

(1s,5s)-8-[(9ar,11as)-9a,11a-dimethyl-9-oxo-1h,2h,3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-methyl-4-methylidene-2,6-dioxabicyclo[3.3.1]nonan-3-one

C28H36O4 (436.2613)

3-hydroxy-4,5,5,10',14',16'-hexamethyl-18'-oxaspiro[oxolane-2,17'-pentacyclo[13.3.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]icosane]-2'(11'),3',5',12'-tetraen-7'-one

C28H36O4 (436.2613)

(13e,16e)-2-oxatricyclo[22.2.2.1³,⁷]nonacosa-1(26),3,5,7(29),13,16,24,27-octaene-5,26,27-triol

C28H36O4 (436.2613)

(2s,3r)-2-[(2r,4s,6e)-4,6-dimethyloct-6-en-2-yl]-6-oxooxan-3-yl (2e,4e,6s)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H40O6 (436.2825)

(2e)-5-[(4r,4ar,5s,6r,8as)-4-hydroxy-5-(hydroxymethyl)-2,5,8a-trimethyl-6-[(3-methylbutanoyl)oxy]-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C25H40O6 (436.2825)

(2r,4as,6as,12br,14as,14br)-10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-1,2,4,5,6,13,14,14b-octahydropicene-3,8-dione

C28H36O4 (436.2613)

(4e,6r)-6-[(1r,9ar,9br,11ar)-9a,11a-dimethyl-4,6-dioxo-1h,2h,3h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2,3-dimethylhept-4-enoic acid

C28H36O4 (436.2613)

3-hydroxy-4,6b,8a,11,12b,14a-hexamethyl-7,8,9,11,12,12a,13,14-octahydro-6ah-picene-2,6,10-trione

C28H36O4 (436.2613)

(6r)-6-[(1s)-1-[(3as,3bs,6s,9ar,9bs,11as)-6-hydroxy-9a,11a-dimethyl-9-oxo-3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3,4-dimethyl-5,6-dihydropyran-2-one

C28H36O4 (436.2613)

2-(4,6-dimethyloct-6-en-2-yl)-6-oxooxan-3-yl 8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H40O6 (436.2825)

(1s,4s,4as,5'r,8as)-4-hydroxy-5,5,5',8a-tetramethyl-2-{[(3-methylbutanoyl)oxy]methyl}-4a,6,7,8-tetrahydro-4h-spiro[naphthalene-1,2'-oxolan]-5'-ylacetic acid

C25H40O6 (436.2825)

(2s,3e,12bs)-3-ethylidene-2-[(1r)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl]-1h,2h,4h,6h,7h,12h,12bh-indolo[2,3-a]quinolizine

C29H32N4 (436.2627)

(1r,2r,10r,11s,14r,15s,16s)-16-[(2r)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]-10,14,16-trimethyl-17-oxapentacyclo[13.2.2.0¹,¹⁴.0²,¹¹.0⁵,¹⁰]nonadeca-4,7-dien-9-one

C28H36O4 (436.2613)

1-[(1s,2r,4as,8ar)-1-[(4s)-4,5-dihydroxy-3-methylidenepentyl]-1,2,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)

(2r,3r,4s,5r)-3,5-dihydroxy-2-{[(2e,6e)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl]oxy}oxan-4-yl 3-methylbut-2-enoate

C25H40O6 (436.2825)

(2s,3s,4r,5r)-2-{[(3e)-4-[(2s,3s)-3-[(3r,4r)-4-ethenyl-4-methyl-3-(prop-1-en-2-yl)cyclohexyl]-3-methyloxiran-2-yl]-2-methylbut-3-en-2-yl]oxy}oxane-3,4,5-triol

C25H40O6 (436.2825)

1-[(1r,2r,4ar,8ar)-1-[(3r)-4-methoxy-3-methyl-4-oxobutyl]-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)

1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O4 (436.2613)

[(1s,2r,4as,8ar)-5-[(acetyloxy)methyl]-1-{2-[(3r,5r)-5-methoxyoxolan-3-yl]ethyl}-1,2-dimethyl-2,3,4,7,8,8a-hexahydronaphthalen-4a-yl]methyl acetate

C25H40O6 (436.2825)

(6bs,8as,11r,12ar,12bs,14ar)-3,11-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C28H36O4 (436.2613)

6-(1-{6-hydroxy-9a,11a-dimethyl-9-oxo-3h,3ah,3bh,4h,6h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3,4-dimethyl-5,6-dihydropyran-2-one

C28H36O4 (436.2613)

3,11-dihydroxy-4,6b,8a,11,12b,14a-hexamethyl-8,9,12,12a,13,14-hexahydro-7h-picene-2,10-dione

C28H36O4 (436.2613)

(1r,3br,4r,5as,9ar,9br,11as)-1-(furan-3-yl)-3b,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,4h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-4-yl acetate

C28H36O4 (436.2613)

1-[1-(4-methoxy-3-methyl-4-oxobutyl)-1,4a,5-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-2-yl]methyl 4-methyl butanedioate

C25H40O6 (436.2825)

(1s,3s,3ar,3br,5ar,6r,9ar,9br,11r,11as)-3-hydroxy-6-(hydroxymethyl)-1-methoxy-3a,3b,6,9a-tetramethyl-7-oxo-dodecahydrocyclopenta[a]phenanthren-11-yl acetate

C25H40O6 (436.2825)

4,8-dihydroxy-12-(3-hydroxy-3-methylpent-4-en-1-yl)-5,5,9-trimethyl-10-oxatricyclo[7.2.1.0¹,⁶]dodecan-3-yl 2-methylbut-2-enoate

C25H40O6 (436.2825)

(2r,3r,4s,5r)-3,5-dihydroxy-2-[(3,7,11-trimethyldodeca-2,6,10-trien-1-yl)oxy]oxan-4-yl 3-methylbut-2-enoate

C25H40O6 (436.2825)

(1r,3r,4s,6r,8r,9r,12s)-4,8-dihydroxy-12-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-5,5,9-trimethyl-10-oxatricyclo[7.2.1.0¹,⁶]dodecan-3-yl (2z)-2-methylbut-2-enoate

C25H40O6 (436.2825)

2-[(6e)-4,6-dimethyloct-6-en-2-yl]-6-oxooxan-3-yl (2e,4e)-8-hydroxy-6-(hydroxymethyl)-4-methylocta-2,4-dienoate

C25H40O6 (436.2825)

(5e)-5-[5-(2,6-dihydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl)-2,3-dihydroxy-3-methylpentylidene]-4-methylfuran-2-one

C25H40O6 (436.2825)

1,4a-dimethyl-5-{3-methyl-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]pent-3-en-1-yl}-6-methylidene-hexahydro-2h-naphthalene-1-carbaldehyde

C25H40O6 (436.2825)